BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15834017)

  • 21. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life.
    Snider BJ; Norton J; Coats MA; Chakraverty S; Hou CE; Jervis R; Lendon CL; Goate AM; McKeel DW; Morris JC
    Arch Neurol; 2005 Dec; 62(12):1821-30. PubMed ID: 16344340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alzheimer's disease: beta-Amyloid protein and tau.
    Morishima-Kawashima M; Ihara Y
    J Neurosci Res; 2002 Nov; 70(3):392-401. PubMed ID: 12391602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyotrophic lateral sclerosis, Parkinson's disease and Alzheimer's disease: phylogenetic disorders of the human neocortex sharing many characteristics.
    Eisen A; Calne D
    Can J Neurol Sci; 1992 Feb; 19(1 Suppl):117-23. PubMed ID: 1571856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Alzheimer's disease. Present and future role of genetics].
    Roks G
    Tijdschr Gerontol Geriatr; 2003 Feb; 34(1):13-20. PubMed ID: 12629906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A molecular genetic overview of familial dementing disorders].
    Tabira T
    Nihon Rinsho; 2004 Apr; 62 Suppl 4():206-13. PubMed ID: 15174672
    [No Abstract]   [Full Text] [Related]  

  • 27. Gene Linkage and Systems Biology.
    Cookson MR
    Adv Neurobiol; 2017; 15():479-489. PubMed ID: 28674994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
    Zhang Q; Zhang X; Sun A
    Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced accumulation of tau in doubly transgenic mice expressing mutant betaAPP and presenilin-1.
    Samura E; Shoji M; Kawarabayashi T; Sasaki A; Matsubara E; Murakami T; Wuhua X; Tamura S; Ikeda M; Ishiguro K; Saido TC; Westaway D; St George Hyslop P; Harigaya Y; Abe K
    Brain Res; 2006 Jun; 1094(1):192-9. PubMed ID: 16713590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphorylation of Tau at S422 is enhanced by Abeta in TauPS2APP triple transgenic mice.
    Grueninger F; Bohrmann B; Czech C; Ballard TM; Frey JR; Weidensteiner C; von Kienlin M; Ozmen L
    Neurobiol Dis; 2010 Feb; 37(2):294-306. PubMed ID: 19781645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular genetics of Alzheimer disease.
    St George-Hyslop PH
    Semin Neurol; 1999; 19(4):371-83. PubMed ID: 10716660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alzheimer's disease: genetic studies and transgenic models.
    Price DL; Tanzi RE; Borchelt DR; Sisodia SS
    Annu Rev Genet; 1998; 32():461-93. PubMed ID: 9928488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Molecular physiopathology of Alzheimer's disease].
    Yamada T
    Fukuoka Igaku Zasshi; 1998 Feb; 89(2):29-33. PubMed ID: 9549175
    [No Abstract]   [Full Text] [Related]  

  • 34. Tau function and dysfunction in neurons: its role in neurodegenerative disorders.
    Avila J; Lim F; Moreno F; Belmonte C; Cuello AC
    Mol Neurobiol; 2002 Jun; 25(3):213-31. PubMed ID: 12109872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel presenilin 1 mutation with profound neurofibrillary pathology in an indigenous Southern African family with early-onset Alzheimer's disease.
    Heckmann JM; Low WC; de Villiers C; Rutherfoord S; Vorster A; Rao H; Morris CM; Ramesar RS; Kalaria RN
    Brain; 2004 Jan; 127(Pt 1):133-42. PubMed ID: 14570818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tau is central in the genetic Alzheimer-frontotemporal dementia spectrum.
    Dermaut B; Kumar-Singh S; Rademakers R; Theuns J; Cruts M; Van Broeckhoven C
    Trends Genet; 2005 Dec; 21(12):664-72. PubMed ID: 16221505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant accentuation of neurofibrillary degeneration in the hippocampus of Alzheimer's disease with amyloid precursor protein 717 and presenilin-1 gene mutations.
    Sudo S; Shiozawa M; Cairns NJ; Wada Y
    J Neurol Sci; 2005 Jul; 234(1-2):55-65. PubMed ID: 15946688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Parkinson disease and amyotrophic lateral sclerosis. Tauopathies, TDP-43 and SOD mutations].
    Le Forestier N; Lacomblez L; Meininger V
    Rev Neurol (Paris); 2009 Jan; 165(1):15-30. PubMed ID: 18808763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alzheimer's disease.
    St George-Hyslop P
    Neurobiol Dis; 2000 Oct; 7(5):546-8. PubMed ID: 11042074
    [No Abstract]   [Full Text] [Related]  

  • 40. No association of the -48CT polymorphism of the presenilin 1 gene with Alzheimer disease in a late-onset sporadic population.
    Araria-Goumidi L; Huguet JB; Lambert JC; Frigard B; Cottel D; Amouyel P; Chartier-Harlin MC
    J Neural Transm (Vienna); 2002 Jul; 109(7-8):1023-7. PubMed ID: 12111439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.